Prediction of Metabolite‐to‐Parent Drug Exposure: Derivation and Application of a Mechanistic Static Model by Ernesto Callegari, Manthena V.S. Varma, R. Scott Obach

Connect to this object online.

Physiologically‐Based Pharmacokinetic Modeling of the Drug-Drug Interaction of the UGT Substrate Ertugliflozin Following Co‐Administration with the UGT Inhibitor Mefenamic Acid by Ernesto Callegari, Jian Lin, Susanna Tse, Theunis C. Goosen, Vaishali Sahasrabudhe

Connect to this object online.

Mini‐Review: Comprehensive Drug Disposition Knowledge Generated in the Modern Human Radiolabeled ADME Study by Douglas K. Spracklin, Danny Chen, Arthur J. Bergman, Ernesto Callegari, R. Scott Obach

Connect to this object online.

End‐to‐end application of model‐informed drug development for ertugliflozin, a novel sodium‐glucose cotransporter 2 inhibitor by Daryl J. Fediuk, Gianluca Nucci, Vikas K. Dawra, Ernesto Callegari, Susan Zhou, Cynthia J. Musante, Yali Liang, Kevin Sweeney, Vaishali Sahasrabudhe

Connect to this object online.

Recommendations for the Design of Clinical Drug-Drug Interaction Studies With Itraconazole Using a Mechanistic Physiologically‐Based Pharmacokinetic Model by Yuan Chen, Tamara D. Cabalu, Ernesto Callegari, Heidi Einolf, Lichuan Liu, Neil Parrott, Sheila Annie Peters, Edgar Schuck, Pradeep Sharma, Helen Tracey, Vijay V. Upreti, Ming Zheng, Andy Z.X. Zhu, Stephen D. Hall

Connect to this object online.